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Abstract
Human herpesvirus-8 (HHV-8) appears to be transmitted mainly by
sexual contact. However, several studies suggest that in developing
countries the infection may be acquired early in life by routes other
than sexual transmission. The present study estimated the seropreva-
lence of HHV-8 in Brazilian children born to HIV-1-infected mothers.
The serum samples were collected in a cross-sectional cohort study
from 99 children born to HIV-infected mothers (median age 3.27
years; range 1.5-13.8 years) attending the outpatient clinic of the
Federal University of São Paulo. IgG antibodies to HHV-8 latency-
associated nuclear antigen and lytic phase antigens were detected by
immunofluorescence assays. The samples tested were collected from
children aged 12 months or older to exclude the possibility of cross-
placental antibody transport. The total prevalence of anti-lytic anti-
bodies in this population (5/99; 5%) reveals that HHV-8 infection can
occur during childhood. Children aged 1.5 to 2 years had a seropreva-
lence of 2% (1/50) and children aged 3.25 to 13.8 years had a
seroprevalence of 8% (4/49). This difference was not statistically
significant, probably because of the small size of the sample, but it
suggests that HHV-8 infection occurs more commonly late in infancy.
Further prospective studies are necessary to evaluate the timing and
risk factors for primary HHV-8 infection in the pediatric population.
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Human herpesvirus-8 (HHV-8), recently
discovered by Chang et al. (1), is etiologi-
cally associated with all forms of Kaposi’s
sarcoma (KS; 2) and other rare malignancies
(3). The routes of HHV-8 transmission differ
according to geographic factors and behav-
ioral patterns. In industrialized western coun-
tries, HHV-8 is transmitted mainly by sexual
contact (4) and its prevalence is low in chil-
dren (5). However, several studies have sug-
gested that in developing countries the infec-
tion may be acquired early in life through
routes other than sexual transmission, in-
volving body fluids like nasal secretions and
saliva (6). In endemic populations, HHV-8
transmission can occur from mother to child
and between sibling, by close interpersonal
contact (7-9). The prevalence of HHV-8 anti-
Brazilian Journal of Medical and Biological Research (2005) 38: 237-240
ISSN 0100-879X Short Communication
238
Braz J Med Biol Res 38(2) 2005
D.M. Machado et al.
bodies ranges from 30-60% in adult African
populations with high rates of KS (10) and
also in children without KS (11,12).
In Brazil, seroprevalence rates of 4.6 and
7.4% were reported among blood donors in
the cities of Vitória and São Paulo, respec-
tively (13,14). Studies conducted in the
Northern region of the country showed an
overall 16.3% prevalence of HHV-8 in ur-
ban communities (15) and a high prevalence
among Brazilian Amerindians (53%), even
among children less than 10 years of age
(41%) (16). Souza et al. (17) studied healthy
children and adults from different cities in
São Paulo State and detected a 1.0 to 4.1%
prevalence of HHV-8 antibodies by latency-
associated nuclear antigen (LANA-IFA) or
lytic phase antigens-immunofluorescence
assays (Lytic-IFA). A high prevalence of
HHV-8 antibodies has been observed in
AIDS patients (39.2%) and an 8.0% fre-
quency of anti-lytic antibodies was recently
found among HIV-1-infected women from
São Paulo (18). Antiretroviral treatment has
dramatically reduced morbidity and mortal-
ity in both adults and children infected with
HIV. Children born to HIV-infected mothers
have survived longer, being exposed to sev-
eral other viral agents, including HHV-8.
Previous studies have reported the occur-
rence of HHV-8 transmission within fami-
lies, from mothers and other relatives to
children via the horizontal route, as well as
significant correlations between the HHV-8
serostatus of mothers and children (8).
In view of these considerations, the ob-
jective of the present study was to estimate
the seroprevalence of HHV-8 among Brazil-
ian children born to HIV-infected mothers.
The study was conducted according to the
ethical guidelines set by the Brazilian Health
Ministry for research on human beings, and
was approved by the Research Ethics Com-
mittee of the Federal University of São Paulo.
The serum samples included in the study
were collected from a cross-sectional cohort
of 99 children (median age, 3.27 years; range
1.5-13.8 years) born to HIV-infected moth-
ers attending the outpatient clinic of the
Federal University of São Paulo.
Of these, 49 were HIV-infected children
(25 females) and 50 (24 females) were verti-
cally exposed but uninfected. The median
age was lower for the uninfected (1.99 years;
range 1.5-2 years) than for the HIV-infected
children (5.36 years; range 3.75-13.8 years).
The samples tested were obtained from
children aged 12 months or older to exclude
the possibility of cross-placental antibody
transport.
Antibodies to HHV-8, LANA-IFA and
Lytic-IFA were detected by IFA. IFA were
performed using the BCBL-1 cell line as
described previously (17). The viral lytic
cycle was induced by incubating BCBL-1
cells with 20 ng/ml 12-o-tetradecanoylphor-
bol-13-acetate (TPA) for 96 h. Punctuate
nuclear staining in untreated BCBL-1 cells
was considered to indicate positivity for anti-
bodies to LANA. Entire cell fluorescence in
about 20% of the TPA-treated cells was
considered to indicate positivity for anti-
bodies to the lytic phase antigens.
Five children (4 HIV-infected and 1 un-
infected) were anti-lytic antibody positive.
According to the Pediatric Classification for
HIV infection in children (Centers for Dis-
ease Control, 1994), 48 of the 49 children
from the infected group already exhibited
HIV-related symptoms (A, B or C) and 1
child was not symptomatic. No HHV-8- sero-
positive children showed clinical evidence
of KS.
The total prevalence of HHV-8 antibodies
in the population studied (5/99, 5%) reveals
that HHV-8 infection can occur during child-
hood. However, in this study we could not
ascertain exactly when the children became
infected, since the infants were not tested at
different intervals after birth. HHV-8 infec-
tion is common in HIV-positive patients,
being significantly higher in HIV-positive
homosexual men as compared to HIV-in-
fected patients showing other behavioral risk
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factors. In the present study, the prevalence
of HHV-8 infection in HIV-infected moth-
ers was not evaluated, and although in previ-
ous studies undertaken in São Paulo State,
the prevalence rate of HHV-8 antibodies in
women ranged from 7.9 to 18.8% (17,18),
there are no data that allow us to compare
these groups. The higher prevalence of HHV-
8 infection in HIV-infected patients than that
seen in healthy Brazilian adults, taken to-
gether with the demonstration of HHV-8
DNA in cervical scrapes from HIV-infected
women (19), suggest that, theoretically, chil-
dren born to HIV-infected mothers could be
at risk of acquiring HHV-8 infection. In the
current study, the prevalence rate of HHV-8
antibodies in children born to HIV-positive
mothers varied according to age group. Chil-
dren aged 1.5 to 2 years had a prevalence rate
of 2% (1/50) and children aged 3.5 to 13.8
years had a prevalence rate of 8.2% (4/49).
This difference was not statistically signifi-
cant, probably because of the small size of
the sample.
In a previous study conducted on healthy
children from the general population of São
Paulo State, not vertically exposed to HIV,
the prevalence rate of HHV-8 antibodies
found in 12- to 23-month-old children (3/
177; 1.7%) was similar to that found in 2- to
10-year-old children (1/98; 1%). Although
we cannot ascertain that the populations par-
ticipating in both studies were comparable,
the results make us wonder if the population
in the present study was exposed to HHV-8
earlier in life.
The Lytic-IFA showed a greater sensitiv-
ity than the LANA-IFA in detecting HHV-8
antibodies. This is not unexpected, since
even in KS patients, the anti-LANA-IFA
shows a lower sensitivity compared to the
Lytic-IFA (20). There are many discrepan-
cies among the studies regarding the results
obtained by the different methods used to
detect HHV-8 antibodies, and the lack of a
“gold standard” hampers the interpretation
of seroepidemiological studies. Further pro-
spective studies are necessary to evaluate the
timing and risk factors for primary HHV-8
infection in the pediatric population.
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